Involvement of the Akt/GSK-3β/CRMP-2 pathway in axonal injury after hypoxic-ischemic brain damage in neonatal rat

Neuroscience

Volumn 216, Issue , 2012, Pages 123-132

  Xiong, T ^a,b   Tang, J ^a,b   Zhao, J ^a,b   Chen, H ^a,b   Zhao, F ^a,b   Li, J ^a,b   Qu, Y ^a,b   Ferriero, D ^c   Mu, D ^a,b,c  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Axon; Brain; Hypoxia ischemia; Injury; Neonatal

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; AMYLOID PRECURSOR PROTEIN; BETA ACTIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN KINASE B; WORTMANNIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; BRAIN CORTEX; CELL STRUCTURE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HISTOPATHOLOGY; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOHISTOCHEMISTRY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; AXONS; DISEASE MODELS, ANIMAL; GLYCOGEN SYNTHASE KINASE 3; HYPOXIA, BRAIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NERVE TISSUE PROTEINS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 84862000889     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.04.052     Document Type: Article

References (31)

1. Brittain J.M., Piekarz A.D., Wang Y., Kondo T., Cummins T.R., Khanna R. An atypical role for collapsin response mediator protein 2 (CRMP-2) in neurotransmitter release via interaction with presynaptic voltage-gated calcium channels. J Biol Chem 2009, 284:31375-31390.
2. Buttrick G.J., Wakefield J.G. PI3-K and GSK-3: Akt-ing together with microtubules. Cell Cycle 2008, 7:2621-2625.
3. Chen J., Zacharek A., Cui X., Shehadah A., Jiang H., Roberts C., Lu M., Chopp M. Treatment of stroke with a synthetic liver X receptor agonist, TO901317, promotes synaptic plasticity and axonal regeneration in mice. J Cereb Blood Flow Metab 2010, 30:102-109.
4. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995, 378:785-789.
5. Frame S., Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem J 2001, 359:1-16.
6. Fukui K., Takatsu H., Koike T., Urano S. Hydrogen peroxide induces neurite degeneration: prevention by tocotrienols. Free Radic Res 2011, 45:681-691.
7. Gao X., Zhang H., Steinberg G., Zhao H. The Akt pathway is involved in rapid ischemic tolerance in focal ischemia in rats. Transl Stroke Res 2010, 1:202-209.
8. Gartner A., Huang X., Hall A. Neuronal polarity is regulated by glycogen synthase kinase-3 (GSK-3beta) independently of Akt/PKB serine phosphorylation. J Cell Sci 2006, 119:3927-3934.
9. Gentleman S.M., Nash M.J., Sweeting C.J., Graham D.I., Roberts G.W. Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury. Neurosci Lett 1993, 160:139-144.
10. Haynes R.L., Billiards S.S., Borenstein N.S., Volpe J.J., Kinney H.C. Diffuse axonal injury in periventricular leukomalacia as determined by apoptotic marker fractin. Pediatr Res 2008, 63:656-661.
11. Hou S.T., Jiang S.X., Aylsworth A., Ferguson G., Slinn J., Hu H., Leung T., Kappler J., Kaibuchi K. CaMKII phosphorylates collapsin response mediator protein 2 and modulates axonal damage during glutamate excitotoxicity. J Neurochem 2009, 111:870-881.
12. Jiang H., Guo W., Liang X., Rao Y. Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3beta and its upstream regulators. Cell 2005, 120:123-135.
13. Jiang S.X., Kappler J., Zurakowski B., Desbois A., Aylsworth A., Hou S.T. Calpain cleavage of collapsin response mediator proteins in ischemic mouse brain. Eur J Neurosci 2007, 26:801-809.
14. Karadottir R., Attwell D. Neurotransmitter receptors in the life and death of oligodendrocytes. Neuroscience 2007, 145:1426-1438.
15. Kilic E., Kilic U., Wang Y., Bassetti C.L., Marti H.H., Hermann D.M. The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia. FASEB J 2006, 20:1185-1187.
16. Leviton A., Gressens P. Neuronal damage accompanies perinatal white-matter damage. Trends Neurosci 2007, 30:473-478.
17. Li D., Qu Y., Mao M., Zhang X., Li J., Ferriero D., Mu D. Involvement of the PTEN-AKT-FOXO3a pathway in neuronal apoptosis in developing rat brain after hypoxia-ischemia. J Cereb Blood Flow Metab 2009, 29:1903-1913.
18. Li L., Qu Y., Mao M., Xiong Y., Mu D. The involvement of phosphoinositid 3-kinase/Akt pathway in the activation of hypoxia-inducible factor-1alpha in the developing rat brain after hypoxia-ischemia. Brain Res 2008, 1197:152-158.
19. Linker R.A., Lee D.H., Demir S., Wiese S., Kruse N., Siglienti I., Gerhardt E., Neumann H., Sendtner M., Luhder F., Gold R. Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis. Brain 2010, 133:2248-2263.
20. Litchfield S., Nagy Z. New temperature modification makes the Bielschowsky silver stain reproducible. Acta Neuropathol 2001, 101:17-21.
21. Martin M., Rehani K., Jope R.S., Michalek S.M. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol 2005, 6:777-784.
22. Miyasaka N., Kuroiwa T., Zhao F.Y., Nagaoka T., Akimoto H., Yamada I., Kubota T., Aso T. Cerebral ischemic hypoxia: discrepancy between apparent diffusion coefficients and histologic changes in rats. Radiology 2000, 215:199-204.
23. Mullonkal C.J., Toledo-Pereyra L.H. Akt in ischemia and reperfusion. J Invest Surg 2007, 20:195-203.
24. Northington F.J., Ferriero D.M., Graham E.M., Traystman R.J., Martin L.J. Early neurodegeneration after hypoxia-ischemia in neonatal rat is necrosis while delayed neuronal death is apoptosis. Neurobiol Dis 2001, 8:207-219.
25. Ramirez S.H., Fan S., Zhang M., Papugani A., Reichenbach N., Dykstra H., Mercer A.J., Tuma R.F., Persidsky Y. Inhibition of glycogen synthase kinase 3beta (GSK3beta) decreases inflammatory responses in brain endothelial cells. Am J Pathol 2010, 176:881-892.
26. Sato Y., Ishida-Nakajima W., Kawamura M., Miura S., Oguma R., Arai H., Takahashi T. Hypoxia-ischemia induces hypo-phosphorylation of collapsin response mediator protein 2 in a neonatal rat model of periventricular leukomalacia. Brain Res 2011, 1386:165-174.
27. Wang F., Liang Z., Hou Q., Xing S., Ling L., He M., Pei Z., Zeng J. Nogo-A is involved in secondary axonal degeneration of thalamus in hypertensive rats with focal cortical infarction. Neurosci Lett 2007, 417:255-260.
28. Yin W., Signore A.P., Iwai M., Cao G., Gao Y., Johnnides M.J., Hickey R.W., Chen J. Preconditioning suppresses inflammation in neonatal hypoxic ischemia via Akt activation. Stroke 2007, 38:1017-1024.
29. Yoshimura T., Arimura N., Kawano Y., Kawabata S., Wang S., Kaibuchi K. Ras regulates neuronal polarity via the PI3-kinase/Akt/GSK-3beta/CRMP-2 pathway. Biochem Biophys Res Commun 2006, 340:62-68.
30. Yoshimura T., Kawano Y., Arimura N., Kawabata S., Kikuchi A., Kaibuchi K. GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity. Cell 2005, 120:137-149.
31. Zhang L., Qu Y., Yang C., Tang J., Zhang X., Mao M., Mu D., Ferriero D. Signaling pathway involved in hypoxia-inducible factor-1alpha regulation in hypoxic-ischemic cortical neurons in vitro. Neurosci Lett 2009, 461:1-6.